Jefferies upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Underperform to Hold with a price target of $50.00 (from $7.00).

For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.

Shares of Sarepta Therapeutic closed at $28.15 yesterday.